Central Surgical Care Limited 07890077 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is Provision of medical services Digita Accounts Production Advanced 6.30.9574.0 true 07890077 2024-01-01 2024-12-31 07890077 2024-12-31 07890077 bus:Director1 1 2024-12-31 07890077 core:RetainedEarningsAccumulatedLosses 2024-12-31 07890077 core:ShareCapital 2024-12-31 07890077 core:CurrentFinancialInstruments 2024-12-31 07890077 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 07890077 core:FurnitureFittings 2024-12-31 07890077 core:OfficeEquipment 2024-12-31 07890077 bus:SmallEntities 2024-01-01 2024-12-31 07890077 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 07890077 bus:FilletedAccounts 2024-01-01 2024-12-31 07890077 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 07890077 bus:RegisteredOffice 2024-01-01 2024-12-31 07890077 bus:Director1 2024-01-01 2024-12-31 07890077 bus:Director1 1 2024-01-01 2024-12-31 07890077 bus:Director2 2024-01-01 2024-12-31 07890077 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 07890077 bus:Agent1 2024-01-01 2024-12-31 07890077 core:ComputerEquipment 2024-01-01 2024-12-31 07890077 core:FurnitureFittings 2024-01-01 2024-12-31 07890077 core:OfficeEquipment 2024-01-01 2024-12-31 07890077 countries:AllCountries 2024-01-01 2024-12-31 07890077 2023-12-31 07890077 bus:Director1 1 2023-12-31 07890077 core:FurnitureFittings 2023-12-31 07890077 core:OfficeEquipment 2023-12-31 07890077 2023-01-01 2023-12-31 07890077 2023-12-31 07890077 core:RetainedEarningsAccumulatedLosses 2023-12-31 07890077 core:ShareCapital 2023-12-31 07890077 core:CurrentFinancialInstruments 2023-12-31 07890077 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 07890077 core:FurnitureFittings 2023-12-31 07890077 core:OfficeEquipment 2023-12-31 iso4217:GBP xbrli:pure

Registration number: 07890077

Central Surgical Care Limited


Annual Report and Unaudited Financial Statements

for the Year Ended 31 December 2024

 

Central Surgical Care Limited

 

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 7

 

Central Surgical Care Limited

 

Company Information

Directors

Mr S Vakis

Mrs L Vakis

Registered office

The Birches
Main Road
Anslow
Burton on Trent
Staffordshire
DE13 9QD

Accountants

Ballards LLP
Chartered AccountantsOakmoore Court
11c Kingswood Road
Hampton Lovett
Droitwich
Worcestershire
WR9 0QH

 

Central Surgical Care Limited

 

(Registration number: 07890077)
Balance Sheet as at 31 December 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

999

1,965

Current assets

 

Debtors

5

35,265

13,388

Cash at bank and in hand

 

174,088

164,020

 

209,353

177,408

Creditors: Amounts falling due within one year

6

(37,684)

(37,482)

Net current assets

 

171,669

139,926

Net assets

 

172,668

141,891

Capital and reserves

 

Called up share capital

100

100

Retained earnings

172,568

141,791

Shareholders' funds

 

172,668

141,891

For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 27 September 2025 and signed on its behalf by:
 

.........................................
Mr S Vakis
Director

.........................................
Mrs L Vakis
Director

 
     
 

Central Surgical Care Limited

 

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

1

General information

The company is a private company limited by share capital, incorporated in UK.

The address of its registered office is:
The Birches
Main Road
Anslow
Burton on Trent
Staffordshire
DE13 9QD

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Central Surgical Care Limited

 

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Computer equipment

33.3% reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Central Surgical Care Limited

 

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 4 (2023 - 4).

 

Central Surgical Care Limited

 

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

4

Tangible assets

Fixtures and fittings
£

Office equipment
£

Total
£

Cost or valuation

At 1 January 2024

650

11,430

12,080

At 31 December 2024

650

11,430

12,080

Depreciation

At 1 January 2024

284

9,831

10,115

Charge for the year

92

874

966

At 31 December 2024

376

10,705

11,081

Carrying amount

At 31 December 2024

274

725

999

At 31 December 2023

366

1,599

1,965

5

Debtors

Current

2024
£

2023
£

Trade debtors

11,840

7,187

Prepayments

4,075

6,201

Other debtors

19,350

-

 

35,265

13,388

6

Creditors

Creditors: amounts falling due within one year

2024
£

2023
£

Due within one year

Trade creditors

-

108

Taxation and social security

36,884

35,073

Accruals and deferred income

800

800

Other creditors

-

1,501

37,684

37,482

7

Related party transactions

 

Central Surgical Care Limited

 

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

Transactions with directors

2024

At 1 January 2024
£

Advances to director
£

Repayments by director
£

At 31 December 2024
£

Mr S Vakis

Overdrawn Directors loan account

(1,501)

46,345

(25,497)

19,347